2
Clinical Trials associated with Human Fibrinogen(Guiyang Qianfeng Biological Product Liability)人纤维蛋白原治疗白血病引起的获得性纤维蛋白原缺乏症的 疗效及安全性的多中心临床研究
[Translation] A multicenter clinical study on the efficacy and safety of human fibrinogen in the treatment of acquired fibrinogen deficiency caused by leukemia
观察人纤维蛋白原治疗获得性纤维蛋白原缺乏症的疗效及安全性
[Translation] To observe the efficacy and safety of human fibrinogen in the treatment of acquired fibrinogen deficiency
人纤维蛋白原(FCH)治疗原发性纤维蛋白原减少或缺乏症的疗效及安全性的多中心临床研究
[Translation] A multicenter clinical study on the efficacy and safety of human fibrinogen (FCH) in the treatment of primary fibrinogen deficiency or deficiency
观察人纤维蛋白原(FCH)治疗原发性纤维蛋白原减少或缺乏症患者的疗效和安全性
[Translation] To observe the efficacy and safety of human fibrinogen (FCH) in the treatment of patients with primary fibrinogen deficiency or deficiency
100 Clinical Results associated with Human Fibrinogen(Guiyang Qianfeng Biological Product Liability)
100 Translational Medicine associated with Human Fibrinogen(Guiyang Qianfeng Biological Product Liability)
100 Patents (Medical) associated with Human Fibrinogen(Guiyang Qianfeng Biological Product Liability)
100 Deals associated with Human Fibrinogen(Guiyang Qianfeng Biological Product Liability)